// App-Quantinova.ai

122 : Real world outcomes of sglt2 inhibition in a hfref population

Researchers

Presenter

  • Patrick Savage

Principal Investigators

  • Daniel McElhatton

  • Michael Campbell

  • Jordan Bamford

  • Rebecca Reid

  • Lana Dixon

Medical Centers

  • Belfast health and Social Care Trust, Royal Victoria Hospital, Belfast, DOW BT14 6AB, United Kingdom

  • Royal Victoria Hospital, Belfast, UK

  • Royal Victoria Hospital

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Heart failure with reduced ejection fraction

Biomarkers

  • N/A

Drug/Treatment

  • BI-10773

  • Dapagliflozin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved